1)日本アレルギー学会喘息ガイドライン専門部会(監),「喘息予防・管理ガイドライン」作成委員(作成):喘息予防・管理ガイドライン2021.協和企画,東京,2021
2)White AA:Aspirin-exacerbated respiratory disease. N Engl J Med 379:1060-1070, 2018
3)Kowalski ML:Diagnosis and management of NSAID-Exacerbated Respiratory Disease(N-ERD)—a EAACI position paper. Allergy 74:28-39, 2019
4)Oguma T:Allergic bronchopulmonary aspergillosis in Japan:a nationwide survey. Allergol Int 67:79-84, 2018
5)「アレルギー性気管支肺真菌症」研究班(編):アレルギー性気管支肺真菌症の診療の手引き.医学書院,東京,2019
6)Agarwal R:A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest 153:656-664, 2018
7)Raghu G:Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 202:e36-e69, 2020
8)Vasakova M:Hypersensitivity pneumonitis:perspectives in diagnosis and management. Am J Respir Crit Care Med 196:680-689, 2017
9)日本呼吸器学会過敏性肺炎診療指針2022作成委員会(編):過敏性肺炎診療指針2022.日本呼吸器学会,2022,pp6-74